What is the main business of Aesculap Chifa?

The main business activity of Aesculap Chifa focuses on manufacture of medical and dental instruments and supplies.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on February 28, 2002.

Where is the headquarters located?

The headquarters is located at: Tysiąclecia 14, 64-300 Nowy Tomyśl.

What is the share capital?

The share capital of the company is PLN 12,680,000 (approx. $3.4 million).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

The company reported a revenue of USD 408,578,313 in 2025, which is an increase of 9.4% compared to 2024.

Is the company profitable?

Yes, the company recorded a net profit of USD 20,272,823 in 2025, meaning the company increased its profit by 0.7%.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to USD 157,315,762 in 2025, representing 41% of all operating expenses.

Aesculap Chifasp. z o.o.

Manufacture of medical and dental instruments and supplies

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2002-02-28

Share capital

12 680 000,00 PLN

Registered address

Tysiąclecia 14, 64-300 Nowy Tomyśl, Poland

Website

bbraun.com

Social media

Electronic delivery address

AE:PL-99819-67573-RBHFJ-24

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 408.58mMedianUSD 251.25kAverageUSD 4.59m

Net profit

This companyUSD 20.27mMedianUSD 8.51kAverageUSD 200.18k

Operating costs

This companyUSD 379.91mMedianUSD 265.43kAverageUSD 4.21m

Assets

This companyUSD 346.31mMedianUSD 224.38kAverageUSD 5.39m

Industry

Bank accounts

Registered as a VAT taxpayer on 1993-07-05. Active

PKO Bank Polski
93 1020 4144 0000 6202 0007 6836
mBank
86 1140 1124 0000 3430 7800 1016
PKO Bank Polski
24 1020 4144 0000 6502 0159 0355

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

Type	Amount
Land (incl. perpetual usufruct)	$1.7M$1,739,267
Buildings and premises	$23.7M$23,678,177

Public aid

145 public aid cases recorded, with a total value of $1,558,622.

Grant date	Purpose	Gross amount	Granting body
Mar 26, 2026	Investment aid for the promotion of energy from renewable sources	––	Zarządca Rozliczeń S.A.
Dec 1, 2025	De minimis aid (in accordance with Commission Regulation 2023/2831)	––	Burmistrz Miasta i Gminy Lwówek
Dec 1, 2025	De minimis aid (in accordance with Commission Regulation 2023/2831)	––	Burmistrz Miasta i Gminy Lwówek

Tenders

5472 tenders recorded as contractor: 2388 national ($77,785,763) and 3084 EU ($7,624,418,206).

Publication date	Subject	Amount	Contracting authority
Oct 15, 2026	Dostawy endoprotez - 2026	––	Samodzielny Publiczny Zespół Zakładów Opieki Zdrowotnej w Janowie Lubelskim
Oct 15, 2026	Dostawa leków dla Szpitala Wojewódzkiego im.dr. Ludwika Rydygiera w Suwałkach	––	Szpital Wojewódzki Im. Dr. Ludwika Rydygiera w Suwałkach
Oct 15, 2026	Dostawa leków dla spzzoz w Przasnyszu	––	Samodzielny Publiczny Zespół Zakładów Opieki Zdrowotnej

Public sector contracts

Aesculap Chifa is the contractor in 2324 public sector contracts, worth PLN 149.70m in total. They were signed with 289 public buyers. The largest number (73) were signed with Wojewódzkie Wielospecjalistyczne Centrum Onkologii I Traumatologii Im.M.Kopernika w Łodzi.

Signed	Subject	Public buyer	Value
Oct 14, 2026	"Dostawa leków", Zadanie nr 3, 20, 26, 40	Zespół Opieki Zdrowotnej w Oławie	PLN 771,018
Oct 13, 2026	Naprawa pompy infuzyjnej B.Braun sn 140598	Uniwersyteckie Centrum Kliniczne	PLN 909.31
Oct 13, 2026	Naprawa pompy infuzyjnej B.Braun sn 616001	Uniwersyteckie Centrum Kliniczne	PLN 824.64
Oct 13, 2026	Naprawa pompy infuzyjnej B.Braun sn 616085	Uniwersyteckie Centrum Kliniczne	PLN 793.04
Oct 13, 2026	Naprawa pompy infuzyjnej B.Braun sn 147619	Uniwersyteckie Centrum Kliniczne	PLN 386.72

Public buyer	Value
Zespół Opieki Zdrowotnej w Oławie	PLN 771,018
Uniwersyteckie Centrum Kliniczne	PLN 909.31
Uniwersyteckie Centrum Kliniczne	PLN 824.64
Uniwersyteckie Centrum Kliniczne	PLN 793.04
Uniwersyteckie Centrum Kliniczne	PLN 386.72

Public procurement disputes (KIO)

Aesculap Chifa has been a party to 25 cases before the National Appeal Chamber (since 2007). It filed 11 appeals (7 upheld, 1 dismissed, 2 discontinued, 1 rejected). In 14 cases it joined the proceedings as a participant.

Date	Case no.	Role	Other party	Outcome
Jun 29, 2026	KIO 2565/26	Participant (on authority's side)	Samodzielny Publiczny Specjalistyczny Zakład Opieki Zdrowotnej „ZDROJE” w Szczecinie	Dismissed
Feb 25, 2026	KIO 240/26	Appellant	Wojewódzki Szpital Wielospecjalistyczny im. dr. Jana Jonstona w Lesznie	Discontinued
Aug 25, 2025	KIO 2877/25	Appellant	Wojewódzki Szpital Zespolony im. Ludwika Perzyny w Kaliszu	Dismissed
Jul 31, 2025	KIO 2675/25	Appellant	Wojewódzki Szpital Specjalistyczny im. Janusza Korczaka w Słupsku Sp. z o. o.	Discontinued
Jul 16, 2024	KIO 2405/24	Participant (on authority's side)	Szpital Uniwersytecki w Krakowie	–

Trademarks

Aesculap Chifa holds 4 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2004.

Mark	Number	Classes	Status	Protected until
CHIFA	Z.416979	10	Protected	Jul 22, 2033
CHIFA	Z.394262	10	Protected	Dec 19, 2031
file removal system(word)	Z.394264	10	Protected	Dec 19, 2031
chifa(word)	Z.394265	10	Protected	Dec 19, 2031
CHIFA	Z.280836	10, 12, 37	Expired	–

Mark	Protected until
CHIFA	Jul 22, 2033
CHIFA	Dec 19, 2031
file removal system(word)	Dec 19, 2031
chifa(word)	Dec 19, 2031
CHIFA	–

Regulatory authorisations

Authority	Type	Status
URE	Electricity generation	Active
URE	Electricity generation Concession amendment	Application
BDO	Waste generation	Active

Authorized Representatives

Agnieszka Kwiatkowska – Attorney-in-fact (joint)

Slawomir Karol Lukaszyk – President of the Management Board

Krzysztof Przemysław Kołodziejski – Management Board Member

Manner of representation

The company is represented by two members of the management board, or by one member of the management board jointly with a commercial proxy. Subject to statutory limitations, the company may also be represented by two commercial proxies within the scope of the commercial proxy.

Supervisory board

Andreas Hahn – Supervisory Board Member

Bert Bender – Supervisory Board Member

Jerzy Perz – Supervisory Board Member

Ownership

Owner	Shares	Share value	Stake
Aesculap International Gmbh w Niemczech	245,787	$3,319,651.54	96.9192%
Others	7,813	$105,524.04	3.0808%

Beneficial owners

Person	Rights

Competitors

Name	Revenue	Website
HTL-StrefaS.A.	$72,297,898.54	htl-strefa.com
Rehasensesp. z o.o.	$44,602,816.03	rehasense.com
JZOS.A.	$41,048,656.33	jzo.com.pl

FAQ

Last updated: 2026-10-10